pirenzepine has been researched along with Depression, Involutional in 17 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
Depression, Involutional: Form of depression in those MIDDLE AGE with feelings of ANXIETY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We measured [(3)H]AF-DX 384 binding in BA 46 and BA 24 from subjects with bipolar disorders (n = 14), major depressive disorders (n = 19), as well as age- and sex-matched controls (n = 19) and the CNS of rats treated with fluoxetine or imipramine." | 3.83 | Changes in Muscarinic M2 Receptor Levels in the Cortex of Subjects with Bipolar Disorder and Major Depressive Disorder and in Rats after Treatment with Mood Stabilisers and Antidepressants. ( Dean, B; Gibbons, AS; Jeon, WJ; Scarr, E, 2016) |
| "All charts of patients meeting DSM-IV criteria for bipolar disorder or unipolar major depressive disorder treated with olanzapine in a private psychiatric practice were reviewed and clinical response was assessed retrospectively using the Clinical Global Impression Scale for Improvement (CGI-I)." | 3.70 | Does olanzapine have antidepressant properties? A retrospective preliminary study. ( Cherry, EL; Ghaemi, SN; Goodwin, FK; Katzow, JA, 2000) |
| " However, no correlation between prolactin levels and dosage could be found." | 1.32 | [Plasma prolactin level and incidence of adverse endocrinologic effects during therapy with atypical neuroleptics]. ( Fric, M; Laux, G, 2003) |
| "Converging evidence indicates that, in controlled drug trials, individuals receiving novel antipsychotic medications have fewer adverse effects than those receiving conventional antipsychotic medications." | 1.31 | Short report: comparison of patient satisfaction and burden of adverse effects with novel and conventional neuroleptics: a naturalistic study. ( Bromet, EJ; Davidson, M; Rabinowitz, J, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 14 (82.35) | 29.6817 |
| 2010's | 1 (5.88) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gibbons, AS | 1 |
| Jeon, WJ | 1 |
| Scarr, E | 1 |
| Dean, B | 1 |
| Truöl, S | 1 |
| Von Hippel, C | 1 |
| Raape, J | 1 |
| König, F | 1 |
| Matthews, JD | 1 |
| Bottonari, KA | 1 |
| Polania, LM | 1 |
| Mischoulon, D | 1 |
| Dording, CM | 1 |
| Irvin, R | 1 |
| Fava, M | 1 |
| Khaldi, S | 1 |
| Kornreich, C | 1 |
| Dan, B | 1 |
| Pelc, I | 1 |
| Miller, TJ | 1 |
| Zipursky, RB | 1 |
| Perkins, D | 1 |
| Addington, J | 1 |
| Woods, SW | 1 |
| Hawkins, KA | 1 |
| Hoffman, R | 1 |
| Preda, A | 1 |
| Epstein, I | 1 |
| Addington, D | 1 |
| Lindborg, S | 1 |
| Marquez, E | 1 |
| Tohen, M | 1 |
| Breier, A | 1 |
| McGlashan, TH | 1 |
| Detweiler, MB | 1 |
| Trinkle, DB | 1 |
| Fric, M | 1 |
| Laux, G | 1 |
| Weisler, RH | 1 |
| Ahearn, EP | 1 |
| Davidson, JR | 1 |
| Wallace, CD | 1 |
| Markowitz, JS | 1 |
| DeVane, CL | 1 |
| Schmitt, A | 1 |
| Braus, DF | 1 |
| Ghaemi, SN | 1 |
| Cherry, EL | 1 |
| Katzow, JA | 1 |
| Goodwin, FK | 1 |
| Edell, WS | 1 |
| Tunis, SL | 1 |
| Weizman, R | 1 |
| Weizman, A | 1 |
| Benazzi, F | 1 |
| Nelson, EB | 1 |
| Rielage, E | 1 |
| Welge, JA | 1 |
| Keck, PE | 1 |
| Rabinowitz, J | 1 |
| Bromet, EJ | 1 |
| Davidson, M | 1 |
| Duggal, HS | 1 |
| Fetchko, J | 1 |
1 review available for pirenzepine and Depression, Involutional
| Article | Year |
|---|---|
Use of atypical antipsychotics in mood disorders.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clinical Trials as Topic; Clozapine; Depres | 2001 |
3 trials available for pirenzepine and Depression, Involutional
| Article | Year |
|---|---|
An open study of olanzapine and fluoxetine for psychotic major depressive disorder: interim analyses.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Depressive Disord | 2002 |
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Comorbidity; Depressive | 2003 |
An open trial of olanzapine in the treatment of patients with psychotic depression.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Depressive Disorder, Major; Female; Humans; Male; Olan | 2001 |
13 other studies available for pirenzepine and Depression, Involutional
| Article | Year |
|---|---|
Changes in Muscarinic M2 Receptor Levels in the Cortex of Subjects with Bipolar Disorder and Major Depressive Disorder and in Rats after Treatment with Mood Stabilisers and Antidepressants.
Topics: Animals; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Cerebral Cortex; Depressive Diso | 2016 |
[Improvement of tardive dyskinesia after treatment with olanzapine].
Topics: Affective Disorders, Psychotic; Aged; Benzodiazepines; Depressive Disorder, Major; Drug Therapy, Com | 2002 |
Usefulness of olanzapine in refractory panic attacks.
Topics: Antipsychotic Agents; Benzodiazepines; Depressive Disorder, Major; Drug Resistance; Female; Humans; | 2003 |
Fluoxetine augmentation with olanzapine for treatment of chronic resistant depression in an elderly patient: a case report.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Depressive Disorder, Major; Dose-Respo | 2003 |
[Plasma prolactin level and incidence of adverse endocrinologic effects during therapy with atypical neuroleptics].
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Depressive Disorder, Major; Dibenzothiaze | 2003 |
Adjunctive use of olanzapine in mood disorders: five case reports.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Delusions; Depressive Disorder, Majo | 1997 |
Suspected ciprofloxacin inhibition of olanzapine resulting in increased plasma concentration.
Topics: Anti-Infective Agents; Antipsychotic Agents; Benzodiazepines; Ciprofloxacin; Cytochrome P-450 CYP1A2 | 1999 |
[Effective treatment of depressive disorder with psychotic symptoms by olanzapine combination therapy].
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Depressive Disorder | 2000 |
Does olanzapine have antidepressant properties? A retrospective preliminary study.
Topics: Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Depress | 2000 |
Antipsychotic treatment of behavioral and psychological symptoms of dementia in geropsychiatric inpatients.
Topics: Aged; Aged, 80 and over; Aggression; Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Depre | 2001 |
Fluoxetine and olanzapine for resistant depression.
Topics: Benzodiazepines; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Fluoxet | 2002 |
Short report: comparison of patient satisfaction and burden of adverse effects with novel and conventional neuroleptics: a naturalistic study.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Depressive Disorder, Majo | 2001 |
Serotonin syndrome and atypical antipsychotics.
Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Benzodiazepines; Depressive Disorder, Major; | 2002 |